Code | CSB-MP016077HU1(F6) |
Abbreviation | Recombinant Human NRG1 protein, partial (Active) |
MSDS | |
Size | $116 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
The recombinant human NRG1 protein is expressed in mammalian cells using a plasmid construct containing the gene sequence coding for residues 20-247 of human NRG1. The NRG1 protein features a C-terminal 6xHis-tag. Its purity exceeds 95% validated by SDS-PAGE, and endotoxin content remains below 1.0 EU/μg, determined via the LAL assay. The NRG1 protein is biologically active, with ELISA results showing specific binding to the human ERBB3 (CSB-MP007765HU). The EC50 is in the range of 18.24-23.66 ng/mL.
Human pro-neuregulin-1, commonly called neuregulin-1 (NRG1), is a member of the neuregulin family of growth factors, which plays a crucial role in various physiological processes, particularly in the nervous system and cardiac function. NRG1 is known for its involvement in the development and maintenance of the peripheral nervous system, as well as its neuroprotective properties in various neurological conditions.
NRG1 signaling is mediated through its receptors ErbB2, ErbB3, and ErbB4. The binding of NRG1 to these receptors initiates signaling pathways such as MAPK, PI3K-Akt, and Fyn-mediated NMDA receptor phosphorylation that are essential for neuronal survival, differentiation, migration, myelination, synaptic function, and glucose metabolism [1][2]. Dysregulation of NRG1 signaling has been implicated in the pathogenesis of neurological and psychiatric disorders such as schizophrenia [3-5]. NRG1 has been shown to promote Schwann cell myelination and support the regeneration of peripheral nerves following injury [6].
In addition to its role in nerve development, NRG1 has significant implications in cardiac health. It has been demonstrated that NRG1 can counteract excessive beta-adrenergic activation, which is a critical factor in heart failure [7]. The neuroprotective effects of NRG1 extend to conditions such as ischemic stroke, where it has been shown to improve neurological outcomes and reduce neuronal death [8][9]. This protective role is attributed to its ability to modulate inflammatory responses and promote cell survival through the activation of various intracellular signaling pathways [10].
References:
[1] C. Li, J. Ma, H. Zhao, B. Blagg, & R. Dobrowsky. Induction of heat shock protein 70 (hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-jun, Asn Neuro, 2012. https://doi.org/10.1042/an20120047
[2] S. Schram, J. Loeb, & F. Song. Disease propagation in amyotrophic lateral sclerosis (als): an interplay between genetics and environment, Journal of Neuroinflammation, vol. 17, no. 1, 2020. https://doi.org/10.1186/s12974-020-01849-7
[3] A. Savonenko, T. Melnikova, F. Laird, K. Stewart, D. Price, & P. Wong. Alteration of bace1-dependent nrg1/erbb4 signaling and schizophrenia-like phenotypes in bace1-null mice, Proceedings of the National Academy of Sciences, vol. 105, no. 14, p. 5585-5590, 2008. https://doi.org/10.1073/pnas.0710373105
[4] A. Law, B. Lipska, C. Weickert, T. Hyde, R. Straub, R. Hashimoto, et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ snps associated with the disease, Proceedings of the National Academy of Sciences, vol. 103, no. 17, p. 6747-6752, 2006. https://doi.org/10.1073/pnas.0602002103
[5] C. Weickert, Y. Tiwari, P. Schofield, B. Mowry, & J. Fullerton. Schizophrenia-associated hapice haplotype is associated with increased nrg1 type iii expression and high nucleotide diversity, Translational Psychiatry, vol. 2, no. 4, p. e104-e104, 2012. https://doi.org/10.1038/tp.2012.25
[6] G. Mòdol‐Caballero, D. Santos, X. Navarro, & M. Herrando-Grabulosa. Neuregulin 1 reduces motoneuron cell death and promotes neurite growth in an in vitro model of motoneuron degeneration, Frontiers in Cellular Neuroscience, vol. 11, 2018. https://doi.org/10.3389/fncel.2017.00431
[7] M. Hintsanen, T. Hintsa, T. Lehtimäki, O. Raitakari, J. Viikari, & L. Keltikangas-Järvinen. Does neuregulin-1 play a role in type a behavior? the cardiovascular risk in young finns study, Behavioral and Brain Functions, vol. 4, no. 1, 2008. https://doi.org/10.1186/1744-9081-4-40
[8] Z. Xu, D. Croslan, A. Harris, G. Ford, & B. Ford. Extended therapeutic window and functional recovery after intraarterial administration of neuregulin-1 after focal ischemic stroke, Journal of Cerebral Blood Flow & Metabolism, vol. 26, no. 4, p. 527-535, 2005. https://doi.org/10.1038/sj.jcbfm.9600212
[9] L. Simmons, M. Surles-Zeigler, Y. Li, G. Ford, G. Newman, & B. Ford. Regulation of inflammatory responses by neuregulin-1 in brain ischemia and microglial cells in vitro involves the nf-kappa b pathway, Journal of Neuroinflammation, vol. 13, no. 1, 2016. https://doi.org/10.1186/s12974-016-0703-7
[10] M. Liu, W. Solomon, J. Cespedes, N. Wilson, B. Ford, & J. Stiles. Neuregulin-1 attenuates experimental cerebral malaria (ecm) pathogenesis by regulating erbb4/akt/stat3 signaling, Journal of Neuroinflammation, vol. 15, no. 1, 2018. https://doi.org/10.1186/s12974-018-1147-z
There are currently no reviews for this product.